Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Pharmacol Ther. 2007 May;81(5):631-3.Click here to read Links
Comment on:
Clin Pharmacol Ther. 2007 Mar;81(3):362-70.

Grapefruit juice, a glass full of drug interactions?

Kirby BJ, Unadkat JD.

Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.

Numerous reports have documented drug interactions with grapefruit juice (GFJ) that occur via inhibition of CYP3A enzymes. As reported by Glaeser et al. in the March 2007 issue of this journal, there is increasing recognition that GFJ may also affect the activity of influx (e.g., OATPs) and efflux (e.g., P-glycoprotein) transporters. This commentary focuses on these interactions between GFJ and drug transporters.

PMID: 17438537 [PubMed - indexed for MEDLINE]